期刊文献+

蛋白芯片法检测幽门螺杆菌CagA、Hsp60和Ure的应用 被引量:4

The application of protein chip test for Helicobacter Pylori CangA,Hsp60 and Ure
原文传递
导出
摘要 目的:应用不同方法调查公共场所从业人员HP感染状况,探讨公共场所服务人员HP感染率及存在的传染隐患。方法:应用福建三强生物化工有限公司提供的幽门螺杆菌快速诊断试剂盒进行Hp的尿素酶快速诊断试验,同时应用幽门螺杆菌蛋白芯片(南京大渊生物技术工程有限责任公司),对142份血样进行CagA、Ure和Hsp60抗体测定。结果:142份公共场所从业人员血样检测HP尿素酶抗体阳性率分别为68.30%(福建三强)和62.68%(南京大渊);CagA毒力株感染者68份,占HP检测人数的47.89%;未检测到Hsp60抗体阳性血样。结论:HP检测可及时提示感染和传染,是否将HP检测纳入公共场所从业人员健康体检。 Objective:Use different methods for public employees of HP infection status and explore public service personnel HP infection rates and existence.Methods: Application of Fujian sanqiang biological chemical Co.,LTD.Offers helicobacter pylori rapid diagnostic kit for Hp′s urease rapid diagnostic tests also applied helicobacter pylori protein microarray(nanjing bigyuan biotechnology engineering limited liability company) determination for 142 blood sample of CagA,Ure,and Hsp60 antibody.Results: 142 blood sample Hp urea antibodies positive tate separately is 68.30%(Fujian sanqiang) and 62.68%(Nanjing dayuan);CagA antibody positive 68 and infected rate is 47.89%.Hsp60 antibody positive samples have been not detected.Conclusion: HP testing can timely clew infection and whether Hp testing use in public places personnel healthy check-up.
出处 《中国卫生检验杂志》 CAS 2010年第12期3308-3309,共2页 Chinese Journal of Health Laboratory Technology
关键词 餐饮服务人员 蛋白芯片法 幽门螺杆菌 Service personnels for repast Protein chip method Helicobacte pylori
  • 相关文献

参考文献11

  • 1顾掌生.幽门螺杆菌与胃外疾病[J].中华内科杂志,2000,39(4):277-278. 被引量:38
  • 2张万岱,胡伏莲,萧树东,等.中国自然人群幽门螺杆菌感染的流行病学调查[R].中国中西医结合学会第十七次全国消化系统疾病学术研讨会.http://d.g.wanfangdata.com.cn/Conference_6186770.aspx.
  • 3潘江波.幽门螺杆菌尿素酶检测460例分析[J/OL].hnp://www.med126.com/edu/200712/17648.shtml.
  • 4路又可.幽门螺杆菌的致病机制研究[J].国外医学(内科学分册),2002,29(4):166-168. 被引量:10
  • 5Yoshiyama H, T Nakazawa. Unique mechanism of Helicohacter pylori for colonizing the gastric mucus [ J ]. Microbes Infect, 2000,2 : 55 - 60.
  • 6Eaton KA, Gilbert JV, Joyce EA, et al. In vivo complementation of ureB restores the ability of Helicobacter pylari to colonize [ J ]. Infect Immun, 2002,70(2) :771 -778.
  • 7Zhang L, Mulrooney SB, Leung AF, et al. Inhibiton of urease by bismuth (Ⅲ) : implications for the mechanism of action of bismuth drugs [ J ]. Biometals. 2006,19:503 - 511.
  • 8Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helieobacter pylori broth culture supernatants with vacuolizing cytotoxin activity [ J ]. Infect lmmun, 1990,58 : 603.
  • 9Crabtree JE, Wyatt JI, Sobala GM, et al. Syetemic and mucasal humoral responses to Helicobacter pylori in gastric cancer[J].Gut. 1993, 34:1339.
  • 10Dunn BE, Vakil NB, Schneider BG, et al. Localization or Helicobaeterpylori urease and heat shock protein in human gastric biopsies[J].InfectImmun, 1997, 65(4) :1181 - 1188.

二级参考文献21

  • 1厉有名,伊藤重二,郡大裕,石井靖,黄怀德.幽门螺杆菌诱发肝硬化大鼠高氨血症的实验研究[J].中华内科杂志,1997,36(2):125-126. 被引量:44
  • 2Eaton KA, Morgan DR, Krakowka S. [ J]. J Med Microbiol, 1992,37(2): 123-127.
  • 3Ferrero RL, Lee A. [ J]. Mircrobiol Ecol Health Dis,1991,4(2): 121-134.
  • 4Dunn BE,Vakil NB,Schneider BG, et al. [J]. Infect Immun, 1997,65(4): 1181-1188.
  • 5Appelmelk BJ, Negrini R, Moran AP, et al. [J].Trends Microbiol, 1997,5 (2): 70-73.
  • 6Moran AP. [J]. FEMS Immunol Med Microbiol, 1995,10(3-4): 271-280.
  • 7Karttunen R. [J]. Clin Exp Immunol, 1991,83(3):396-400.
  • 8Cave DR. [J]. Gastroenterology,1997,113(6 Suppl):S9-14.
  • 9Murakami M, Saita H, Teramura S, et al. [J]. Gastroenterology, 1993,105(6): 1710-1715.
  • 10Blaser MJ. [ J]. Scand J Gastroenterol, 1994,29(Suppl 205 ): 1-5.

共引文献46

同被引文献34

  • 1朱永红.幽门螺杆菌持续性感染机理[J].中国人兽共患病杂志,2005,21(10):910-913. 被引量:5
  • 2刘玉梅,谢会忠,刘素辉,布海里且木.吾甫尔,王亚男,德里夏提.依米提.维吾尔族、汉族慢性胃炎患者中HLA-DRB1*12等位基因与幽门螺杆菌感染的关系[J].新疆医科大学学报,2007,30(5):461-463. 被引量:2
  • 3林三仁.消化内科学高级教程[M].北京:人民军医出版社,2011:149-150.
  • 4Iakovenko EP,Grigor′ev PI,Iakovenko AV,et al.Effectsof probiotic bifiform on efficacy of Helicobacter pylori in-fection treatment[J].Ter Arkh,2006,78(2):21-26.
  • 5Sheu BS,Wu JJ,Lo CY,et al.Impact of supplement withlactobacillus and bifidobacterium containing yogurt on tri-ple therapy forhelicobacter pylori eradication[J].AlimentPharmacol Ther,200,16(9):1669-1675.
  • 6Sugiyama T,Asaka M.Helicobacter pylori infection andgastric cancer[J].Med Electron Microsc,2004,37(3):149-157.
  • 7Peek RM,Blaser MJ.Helicobacter pylori and gastrointes-tinal tract adenocarcinomas[J].Nat Rev Cancer,2002,2(1):28-37.
  • 8Abbott A.Gut feeling secures medical Nobel for Austral-ian doctors[J].Nature,2005,437(7060):801-802.
  • 9Kohda K,Tanaka K,Aiba Y,et al.Role of apoptosis in-duced by helicobacter pylori infection in the developmentof duodenal ulcer[J].Gut,2002,44(4):456-462.
  • 10Charmandari E,Tsigos C,Chrousos G.Endocrinology ofthe stress response[J].Annu Rev Physiol,2005,67(4):259-284.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部